Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach

被引：0
|
作者：
Yongsheng Chen
Lichen Teng
Wenhua Liu
Yan Cao
Dexin Ding
Wentao Wang
Hui Chen
Changfu Li
Ruihua An
机构：
[1] Harbin Medical University Cancer Hospital,Department of Urology
[2] The Second Affiliated Hospital of Harbin Medical University,Intensive Care Unit (ICU) Department
[3] The First Affiliated Hospital of Harbin Medical University,Department of Urology
来源：
Cancer Cell International | / 16卷
关键词：
Clear cell renal cell carcinoma; MicroRNAs; Differentially expressed genes; Protein–protein interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
    Vermassen, T.
    De Meulenaere, A.
    Van de Walle, M.
    Rottey, Sylvie
    ACTA CLINICA BELGICA, 2017, 72 (01) : 12 - 18
  • [22] MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
    Swearson, Samuel
    Rataan, Aseel O.
    Eliason, Steven
    Amendt, Brad A.
    Zakharia, Yousef
    Salem, Aliasger K.
    Ho, Thai
    Rustum, Youcef M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [23] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, Xi
    Zhu, Shuxuan
    Liu, Wangrui
    Wu, Xinrui
    Wei, Gaomeng
    Zhang, Ji
    Anwaier, Aihetaimujiang
    Chen, Cong
    Ye, Shiqi
    Che, Xiangxian
    Xu, Wenhao
    Qu, Yuanyuan
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17451 - 17466
  • [24] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, X.
    Shuxuan, Z.
    Qu, Y.
    Hailiang, Z.
    Dingwei, Y.
    EUROPEAN UROLOGY, 2024, 85 : S1055 - S1055
  • [25] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Xi Tian
    Shuxuan Zhu
    Wangrui Liu
    Xinrui Wu
    Gaomeng Wei
    Ji Zhang
    Aihetaimujiang Anwaier
    Cong chen
    Shiqi Ye
    Xiangxian Che
    Wenhao Xu
    Yuanyuan Qu
    Hailiang Zhang
    Dingwei Ye
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17451 - 17466
  • [26] Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
    Amano, Tsukuru
    Murakami, Atsushi
    Murakami, Takashi
    Chano, Tokuhiro
    ANTIOXIDANTS, 2021, 10 (02) : 1 - 15
  • [27] Modeling clear cell renal cell carcinoma and therapeutic implications
    Wolf, Melissa M.
    Rathmell, W. Kimryn
    Beckermann, Kathryn E.
    ONCOGENE, 2020, 39 (17) : 3413 - 3426
  • [28] Modeling clear cell renal cell carcinoma and therapeutic implications
    Melissa M. Wolf
    W. Kimryn Rathmell
    Kathryn E. Beckermann
    Oncogene, 2020, 39 : 3413 - 3426
  • [29] Genome-wide gene expression profiles of clear cell renal cell carcinoma: Identification of molecular targets for treatment of renal cell carcinoma
    Hirota, Eiji
    Yan, Liang
    Tsunoda, Tatsuhiko
    Ashida, Shingo
    Fujime, Makoto
    Shuin, Taro
    Miki, Tsuneharu
    Nakamura, Yusuke
    Katagiri, Toyomasa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (04) : 799 - 827
  • [30] Orellanine specifically targets renal clear cell carcinoma
    Buvall, Lisa
    Hedman, Heidi
    Khramova, Alina
    Najar, Deman
    Bergwall, Lovisa
    Ebefors, Kerstin
    Sihlbom, Carina
    Lundstam, Sven
    Herrmann, Anders
    Wallentin, Hanna
    Roos, Emelie
    Nilsson, Ulf A.
    Johansson, Martin
    Tornell, Jan
    Haraldsson, Borje
    Nystrom, Jenny
    ONCOTARGET, 2017, 8 (53) : 91085 - 91098
12345